Compass Therapeutics, Inc.: Form 8-K, filed Nov 2, 2022
Filed with the SEC on Nov 2, 2022 and accepted by EDGAR at Nov 2, 2022, 21:00 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001171843-22-007012. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.